ICCON
TMO icon

Investment Counsel Company of Nevada’s Thermo Fisher Scientific TMO Stock Holding History

Investment Counsel Company of Nevada’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-801
Closed -$325K – 86
2025
Q2 		$325K Hold
801
– – 0.66% 27
2025
Q1 		$399K Buy
+801
New +$434K 0.91% 24

Other funds holding TMO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Investment Counsel Company of Nevada's TMO Position: Q3 2025 in Review

Investment Counsel Company of Nevada sold out of Thermo Fisher Scientific (TMO) in Q3 2025, closing a stake of 801 shares — an estimated $325K sold.

Investment Counsel Company of Nevada first reported a position in TMO in Q1 2025 and held it in 2 quarters. The position peaked at $399K in Q1 2025. 2,510 funds tracked by Wall St. Rank hold TMO as of Q3 2025.

  • Investment Counsel Company of Nevada reported no remaining Thermo Fisher Scientific position as of Q3 2025 after selling out during the quarter.
  • Investment Counsel Company of Nevada sold 801 Thermo Fisher Scientific shares in Q3 2025, an estimated $325K.
  • Investment Counsel Company of Nevada first reported a position in Thermo Fisher Scientific in Q1 2025 and held it in 2 quarters.
  • Investment Counsel Company of Nevada's Thermo Fisher Scientific position peaked at $399K in Q1 2025.
  • 2,510 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q3 2025.

Based on Investment Counsel Company of Nevada's 13F filing for Q3 2025, filed 13 Nov 2025.